Your browser is no longer supported. Please, upgrade your browser.
Settings
JNJ Johnson & Johnson daily Stock Chart
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E23.23 EPS (ttm)5.42 Insider Own0.07% Shs Outstand2.69B Perf Week0.14%
Market Cap338.59B Forward P/E14.68 EPS next Y8.58 Insider Trans-7.24% Shs Float2.68B Perf Month2.69%
Income14.85B PEG2.99 EPS next Q2.07 Inst Own67.90% Short Float0.59% Perf Quarter-3.59%
Sales78.69B P/S4.30 EPS this Y-8.50% Inst Trans-0.15% Short Ratio2.37 Perf Half Y-13.03%
Book/sh23.58 P/B5.34 EPS next Y5.60% ROA0.80% Target Price142.48 Perf Year-4.50%
Cash/sh5.65 P/C22.27 EPS next 5Y7.77% ROE1.80% 52W Range118.62 - 148.32 Perf YTD-9.87%
Dividend3.60 P/FCF36.22 EPS past 5Y7.10% ROI15.70% 52W High-15.80% Beta0.71
Dividend %2.86% Quick Ratio1.20 Sales past 5Y2.60% Gross Margin66.30% 52W Low5.28% ATR1.68
Employees134000 Current Ratio1.60 Sales Q/Q12.60% Oper. Margin22.30% RSI (14)52.06 Volatility1.14% 1.28%
OptionableYes Debt/Eq0.51 EPS Q/Q-0.40% Profit Margin1.60% Rel Volume1.10 Prev Close125.93
ShortableYes LT Debt/Eq0.47 EarningsJul 17 BMO Payout616.60% Avg Volume6.60M Price124.89
Recom2.40 SMA201.08% SMA501.30% SMA200-5.82% Volume684,267 Change-0.83%
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Oct-09-17Upgrade Wells Fargo Market Perform → Outperform
Sep-25-17Initiated Citigroup Neutral $140
Sep-20-17Downgrade Goldman Neutral → Sell $125 → $130
Jul-21-17Downgrade BTIG Research Neutral → Sell $110
Jul-21-17Downgrade Alembic Global Advisors Neutral → Underweight
Jul-20-17Resumed Credit Suisse Outperform $148
Jul-05-17Reiterated Morgan Stanley Overweight $135 → $140
May-18-17Reiterated Stifel Hold $124 → $128
Jul-16-18 08:01AM  The Zacks Analyst Blog Highlights: Johnson & Johnson, Novartis, UnitedHealth and Microsoft Zacks
05:13AM  5 Top Stock Trades for Monday Buy Netflix Ahead of Earnings? InvestorPlace
Jul-13-18 07:55PM  Johnson & Johnson Ordered to Pay $4.69 Billion in Cancer Case GoBankingRates
07:01PM  Jim Cramer: This Market Isn't Done Going Higher TheStreet.com
06:55PM  Johnson & Johnson still battling thousands of cases involving its baby powder CBS News Videos
05:28PM  Why Johnson & Johnson, Cisco Systems, and Ingredion Slumped Today Motley Fool
05:11PM  Why J&J Investors Aren't So Concerned About $4.69B Talc Verdict Bloomberg Video
05:11PM  Why J&J Investors Aren't So Concerned About $4.69B Talc Verdict Bloomberg
05:11PM  Wells Fargo and AT&T slide while Walmart and Terex climb Associated Press
05:08PM  Correction: Talc Powder-Cancer Lawsuit story Associated Press
04:59PM  US STOCKS-S&P 500 at five-month high, but banks weigh after results Reuters
04:49PM  J&J vows to overturn $4.7 billion talc verdict but experts see hurdles Reuters
04:48PM  Despite some wobbles, stocks end the week with more gains Associated Press
04:13PM  J&J vows to overturn $4.7 billion talc verdict but experts see hurdles Reuters
04:05PM  Stocks End Slightly Higher; Indexes Post Gains For Week TheStreet.com
03:52PM  J&J to pay $4.7 bln in cancer case Reuters Videos
03:36PM  US STOCKS-S&P 500 at five-month high, but banks weigh after results Reuters
03:01PM  The Johnson & Johnson Talc Lawsuit Isnt Over Yet InvestorPlace
02:51PM  Johnson & Johnson ordered to pay $4.7 billion in talcum p... CNBC Videos
02:31PM  Bayer, J&J Win Ruling That Upholds Patent for Xarelto Drug Bloomberg
02:29PM  Stocks shuffle toward another weekly gain as oil prices rise Associated Press
02:24PM  J&J (JNJ) to Pay $4.69 Billion to Some Women in Talc Lawsuit Zacks
01:48PM  J&J's $4.69 Billion Talc Verdict May Open Floodgates to Suits Bloomberg
01:44PM  Jury Awards Nearly $4.7 Billion In Powder Case Associated Press Videos
01:22PM  The Midday Rundown: July 13, 2018 CNBC Videos
01:11PM  The Late Morning Rundown: July 13, 2018 CNBC Videos
01:06PM  US STOCKS-S&P hits 5-month high as industrials, energy boost; banks weigh Reuters
12:19PM  Updated: J&J Slumps on $4.7 Billion Award to Cancer Patients Barrons.com
12:15PM  US STOCKS-Industrials, energy push S&P to 5-month high; banks weigh Reuters
11:22AM  Stocks - Wells Fargo, Johnson & Johnson, AT&T Slump in Pre-market, JP Morgan gains Investing.com
11:16AM  2 Dow Stocks for a Volatile Market Investopedia
11:02AM  Johnson & Johnson -- Moody's: Talc award against J&J is credit negative Moody's
11:00AM  The Top 5 Johnson & Johnson Shareholders (JNJ) Investopedia
10:29AM  US STOCKS-Wall Street flat as industrials offset slide in bank stocks Reuters
10:15AM  Better Buy: Amgen Inc. vs. Johnson & Johnson Motley Fool
10:09AM  Attorney: J&J won't be 'intimidated' into removing talc products after $4.7 billion cancer case damages CNBC
10:04AM  J&J Ordered to Pay $4.14 Billion Punitive Damages Bloomberg
09:34AM  Johnson & Johnson Tumbles After $4.7 Billion Baby Powder-Cancer Link Verdict TheStreet.com
09:16AM  US STOCKS-Futures flat as Wall St banks report mixed results Reuters
08:58AM  Morning Movers: AT&T Sinks, JPMorgan Jumps, J&J Slides Barrons.com
08:51AM  Will J&J's (JNJ) Pharma Segment Strength Drive Q2 Earnings? Zacks
08:50AM  Pharma Stock Roundup: PFE to Split Into 3 Units, J&J to Pay $4.7B in Talc Lawsuit Zacks
08:43AM  JNJ vs. NVS: Which Stock is Better Pre Q1 Earnings? Zacks
08:34AM  Johnson & Johnson ordered to pay $4.7 billion in talc pow... CNBC Videos
08:16AM  JPMorgan, AT&T-Time Warner, J&J, Apple and Blue Origin - 5 Things You Must Know TheStreet.com
07:47AM  US STOCKS-Futures flat as JP Morgan kicks off earnings season Reuters
07:45AM  Stocks making the biggest moves premarket: JPM, DIS, BLK, T, JNJ, MCD & more CNBC
06:13AM  Johnson & Johnson ordered to pay record $4.7bn damages over talc cancer lawsuit The Independent
06:03AM  J&J hit with $4.7B verdict in talcum powder case CNBC Videos
05:30AM  Does J&Js Baby Powder Cause Cancer? A Jury Just Said Yes With an Enormous $4.69 Billion Penalty Fortune
12:58AM  PRESS DIGEST -Wall Street Journal - July 13 Reuters
Jul-12-18 08:36PM  Jury orders J&J to pay $4.7 billion in Missouri asbestos cancer case Reuters
08:33PM  [$$] J&J Hit With $4.7 Billion Jury Verdict in Baby Powder Suit The Wall Street Journal
08:17PM  Johnson & Johnson Hit by $4.7 Billion Jury Verdict in Ovarian Cancer Case TheStreet.com
08:11PM  Jury orders J&J to pay $4.7 billion in Missouri asbestos cancer case Reuters
07:57PM  Johnson & Johnson's Official Statement in Response to Today's Verdict in St. Louis Trial PR Newswire
07:45PM  Nearly $4.7 billion awarded in baby powder lawsuit Associated Press
07:23PM  St. Louis Jury Returns $4.69 Billion Verdict in First Trial Linking Baby Powder, Asbestos and Ovarian Cancer PR Newswire
07:14PM  Jury orders J&J to pay $4.7 billion in Missouri asbestos cancer case Reuters
07:12PM  The Latest: Jury awards nearly $4.7 billion in powder case Associated Press
06:42PM  J&J Ordered to Pay $4.14 Billion Punitive Damages Bloomberg
06:20PM  Cramer: Most market-watchers are wrong. Stocks just aren't that expensive CNBC
05:46PM  REPLAY: Jim Cramer on Broadcom, CA, Johnson & Johnson, Citigroup & Canopy Growth TheStreet.com
05:28PM  Jury orders J&J to pay $550 mln in Missouri asbestos cancer case Reuters
04:07PM  Markets Right Now: Tech gains push Nasdaq to all-time high Associated Press
03:40PM  J&J Ordered to Pay $550 Million in Talc Asbestos Cancer Case Bloomberg
03:21PM  Drug Makers Can't Cure Investor Impatience Barrons.com
02:50PM  Why Johnson & Johnson Stock Has Lost 13% So Far in 2018 Motley Fool
01:42PM  Bank Earnings: JPMorgan, Wells Fargo And Citigroup Are Slated To Report Friday Morning Benzinga
12:51PM  Johnson & Johnson's Breakout May Boost Stock 11% Investopedia
12:23PM  Two Dow stocks to buy and one to fade in a volatile market CNBC
11:25AM  Why Jim Cramer Is Bullish on Johnson & Johnson Shares TheStreet.com
10:28AM  Goldman Sachs Swaps Perrigo, Johnson & Johnson Ratings Benzinga
09:29AM  J&J (JNJ) to Set Pharma Q2 Earnings in Motion: What's Up? Zacks
Jul-11-18 08:15AM  Benzinga's Daily Biotech Pulse: Pfizer To Defer Price Hikes, Idera-BioCryst Merger Falls Through, ArQule To Offer Shares Benzinga
01:21AM  Idorsia raises 505 mln Sfr from shares, bonds to fund pipeline Reuters
Jul-09-18 09:57AM  Johnson & Johnson Stock Only Benefits from Big Moves That May Not Come InvestorPlace
Jul-08-18 03:15PM  Why bluebird bio's Shares Have Tumbled 11.9% in 2018 So Far Motley Fool
Jul-06-18 02:46PM  Why Geron Corp. Stock Has Skyrocketed 90.6% in 2018 (So Far) Motley Fool
02:44PM  What the Second Half of 2018 Has in Store for Investors InvestorPlace
11:54AM  Dont Buy Biogen Stock on the Promise of an Alzheimers Breakthrough InvestorPlace
09:35AM  Biogen's Alzheimer Disease Candidate Succeeds in Phase II Zacks
09:15AM  3 Buy-Rated Large Cap Pharma Stocks to Boost Health in July Zacks
09:13AM  Trade of the Day: Novocure Ltd (NVCR) InvestorPlace
07:55AM  Free Pre-Market Technical Recap on Sanofi and Three Additional Drug Makers Stocks ACCESSWIRE
Jul-05-18 03:35PM  Fed minutes warn of rising trade risks Yahoo Finance Video
01:53PM  Everett-based Fortive Corp. is eager to deploy its $4B M&A war chest American City Business Journals
01:33PM  Kiplinger Dividend 15: CVS Interrupts Its String of Hikes Kiplinger
12:03PM  Pfizer's Stock Ready for a 10% Rebound Investopedia
Jul-04-18 05:03PM  Brazil police arrest GE Latin America head, 21 others, in probe Reuters
12:20PM  Brazil police arrest GE Latin America head, 21 others, in probe Reuters
06:09AM  [$$] GE Latin America boss arrested over cartel claims Financial Times
Jul-03-18 01:51PM  How to Invest in Pharmaceutical Stocks: A Beginner's Guide Motley Fool
12:45PM  Stocks Drift Lower; Micron Slumps On China Ruling; Royal Gold Breaks Out Investor's Business Daily
09:08AM  Your first trade for July 3, 2018 CNBC
Jul-02-18 05:30PM  Final Trade: JNJ, JD & CAR CNBC Videos
10:52AM  7 ETFs Where Dividends and Low Volatility Meet InvestorPlace
Jun-29-18 11:06PM  Missouri appeals court tosses $55 million J&J talc-powder verdict Reuters
06:39PM  Missouri appeals court tosses $55 million J&J talc-powder verdict Reuters
06:23PM  Missouri appeals court tosses $55 mln J&J talc-powder verdict Reuters
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. Its Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, RoC, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads under the STAYFREE and CAREFREE brands, and tampons under the o.b. brand; wound care products comprising adhesive bandages under the BAND-AID brand and first aid products under the NEOSPORIN brand. The company's Pharmaceutical segment offers various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, cardiovascular and metabolic, and pulmonary hypertension diseases. Its Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; diabetes care products that include blood glucose monitoring; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Option Exercise90.44155,34214,049,130357,906Feb 20 07:46 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Sale129.86155,34220,172,401202,564Feb 20 07:46 PM
Caruso Dominic JExec VP, Finance; CFOFeb 09Option Exercise0.0010,6010154,703Feb 13 06:54 PM
Duato JoaquinExec VP, WW Chair, PharmaFeb 09Option Exercise0.009,812078,348Feb 13 06:54 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 09Option Exercise0.005,830069,992Feb 13 06:54 PM
Gorsky AlexChairman, CEOFeb 09Option Exercise0.0033,1650285,990Feb 13 06:54 PM
PETERSON SANDRA EExec VP, Group WW ChairmanFeb 09Option Exercise0.0011,445070,205Feb 13 06:54 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 09Option Exercise0.0013,2520181,655Feb 13 06:55 PM
Ullmann Michael HExec VP, General CounselFeb 09Option Exercise0.005,9530115,257Feb 13 06:55 PM
Kapusta Ronald AController, CAOFeb 09Option Exercise0.002,702032,666Feb 13 06:55 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 02Option Exercise0.0032,688032,688Feb 06 04:21 PM
Stoffels PaulusExec VP, Chief Scientific OffOct 31Option Exercise0.0075,4920203,142Nov 02 05:01 PM
Stoffels PaulusExec VP, Chief Scientific OffJul 24Option Exercise72.54102,6927,449,278230,342Jul 26 11:49 AM
Stoffels PaulusExec VP, Chief Scientific OffJul 24Sale133.14102,69213,672,629127,650Jul 26 11:49 AM
Caruso Dominic JExec VP, Finance; CFOJul 20Option Exercise61.7582,5915,099,994226,693Jul 24 11:06 AM
Caruso Dominic JExec VP, Finance; CFOJul 20Sale136.7282,59111,291,478144,102Jul 24 11:06 AM